KYNTRA BIO, INC. KYNB 29.3
Health Care · NASDAQ · Data as of 2026-08-13
KYNTRA BIO, INC. (KYNB) has delivered -26.0% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1886 of 1983 stocks overall and #242 of 263 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
29.3
Overall Rank
#1886 / 1983
Sector Rank
#242 / 263
Revenue CAGR
-26.0%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio